Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1

[1]  Antonio Rosato,et al.  A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. , 2011, Cancer cell.

[2]  Young Sun,et al.  p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis , 2010, Oncogene.

[3]  F. Dick,et al.  An Overlapping Kinase and Phosphatase Docking Site Regulates Activity of the Retinoblastoma Protein , 2010, Nature Structural &Molecular Biology.

[4]  M. Prados,et al.  Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts. , 2010, Cancer research.

[5]  Jeffrey G. Pelton,et al.  Phosphorylation-induced Conformational Changes in the Retinoblastoma Protein Inhibit E2F Transactivation Domain Binding* , 2010, The Journal of Biological Chemistry.

[6]  A. Giordano,et al.  CDK inhibitors: from the bench to clinical trials. , 2010, Current drug targets.

[7]  A. Ryo,et al.  Pin1 Catalyzes Conformational Changes of Thr-187 in p27Kip1 and Mediates Its Stability through a Polyubiquitination Process* , 2009, The Journal of Biological Chemistry.

[8]  M. Pellecchia,et al.  Discovery and Binding Studies on a Series of Novel Pin1 Ligands , 2009, Chemical biology & drug design.

[9]  I. Raška,et al.  Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha. , 2009, Cancer research.

[10]  W. Hahn,et al.  SV40 small T antigen and PP2A phosphatase in cell transformation , 2008, Cancer and Metastasis Reviews.

[11]  C. Tribioli,et al.  Highly Conserved Non-Coding Sequences and the 18q Critical Region for Short Stature: A Common Mechanism of Disease? , 2008, PloS one.

[12]  Yuliang Wu,et al.  Detecting protein–protein interactions by far western blotting , 2007, Nature Protocols.

[13]  W. Gu,et al.  Non-transcriptional control of DNA replication by c-Myc , 2007, Nature.

[14]  M. Mumby.  PP2A: Unveiling a Reluctant Tumor Suppressor , 2007, Cell.

[15]  M. Bowman,et al.  Structural basis for high-affinity peptide inhibition of human Pin1. , 2007, ACS chemical biology.

[16]  A. Giordano,et al.  A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo , 2007, Oncogene.

[17]  A. Giordano,et al.  Interaction of PP2A catalytic subunit with Rb2/p130 is required for all‐trans retinoic acid suppression of ovarian carcinoma cell growth , 2006, Journal of cellular physiology.

[18]  Akira Yamaguchi,et al.  Stable Suppression of Tumorigenicity by Pin1-Targeted RNA Interference in Prostate Cancer , 2005, Clinical Cancer Research.

[19]  Anthony Scime,et al.  Pocket Protein Complexes Are Recruited to Distinct Targets in Quiescent and Proliferating Cells , 2005, Molecular and Cellular Biology.

[20]  J. Sowadski,et al.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers. , 2004, The American journal of pathology.

[21]  A. Means,et al.  Pin1 regulates the timing of mammalian primordial germ cell proliferation , 2003, Development.

[22]  Sam W. Lee,et al.  PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells , 2002, Molecular and Cellular Biology.

[23]  S. Rane,et al.  Germ Line Transmission of the Cdk4R24C Mutation Facilitates Tumorigenesis and Escape from Cellular Senescence , 2002, Molecular and Cellular Biology.

[24]  T. Jacks,et al.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. , 2000, Genes & development.

[25]  J. Herman,et al.  In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Davies,et al.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein , 1999, Nature.

[27]  L. Leffet,et al.  Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression. , 1999, Experimental Cell Research.

[28]  G. Fischer,et al.  Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. , 1998, Biochemistry.

[29]  E. Harlow,et al.  Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs , 1997, Oncogene.

[30]  T. Hunter,et al.  A human peptidyl–prolyl isomerase essential for regulation of mitosis , 1996, Nature.

[31]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Chin-Lee Wu,et al.  Copyright � 1995, American Society for Microbiology In Vivo Association of E2F and DP Family Proteins , 1995 .

[33]  Sushovan Guha,et al.  The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest , 1994, Cell.

[34]  J. Bartek,et al.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. , 1994, Cancer research.

[35]  S. van den Heuvel,et al.  Distinct roles for cyclin-dependent kinases in cell cycle control. , 1993, Science.

[36]  D. Livingston,et al.  Specific enzymatic dephosphorylation of the retinoblastoma protein , 1993, Molecular and cellular biology.

[37]  A. Giordano,et al.  RB gene family: Genome‐wide ChIP approaches could open undiscovered roads , 2010, Journal of cellular biochemistry.

[38]  A. Giordano,et al.  Growth control by the retinoblastoma gene family. , 2003, Methods in molecular biology.

[39]  Qiang Yu,et al.  IGF‐1 induces Pin1 expression in promoting cell cycle S‐phase entry , 2002, Journal of cellular biochemistry.